Rinol Alaj

Contact Rinol

Rinol Alaj

Senior Director, Head of Clinical Outcomes Assessment & Patient Innovation

Regeneron

Rinol Alaj is Senior Director, Head of Clinical Outcomes Assessment (COA) and Patient Innovation at Regeneron. His professional focus is centered around integrated innovation, design thinking, and clinical operation with 15+ years of experience in the startup and pharma industries. A savvy, results-oriented leader, Mr Alaj has proven success in transforming and building eCOA organizations from the ground up. He received his undergraduate and graduate degrees in computer science from New Jersey Institute of Technology, where he also went on to earn his MBA. Mr Alaj is currently pursuing his Master’s in Public Health – Epidemiology and Biostats program at CUNY Graduate School of Public Health and Health Policy.

Talks About
#ClinicalDataManagement #EDC #Inform

Preferred Locations
#UnitedStates

Speaking Engagements

Mobile Tech in Clinical Trials

Paid

This conference helped R&D operation executives support more patients remotely and to understand where these technologies will and won’t work to ensure full patient support while managing invaluable data collection.

19-19 September 2023

Healthcare

DPHARM 2023

Paid

DPHARM Idol Disrupt was a series of quick-fire presentations where you see bold and daring startups pitch their disruptive technologies to the most discerning judges. The Q&A provided amazing shared learnings on how to properly assess new technologies. This section of DPHARM kicked off with an update from the 2022 Winner, Acclinate.

20-22 September 2023

Healthcare

Claim Your Profile Request

Speaker Contact Request

SPEAKER

Rinol Alaj

Senior Director, Head of Clinical Outcomes Assessment & Patient Innovation

Speaking Engagements

Mobile Tech in Clinical Trials

DPHARM 2023